2020/12/31 by Jacek Siewiera, Judyta Mews, Siewiera, Jacek +7
Medicine · #Dermatological and COVID-19 studies #Diabetic Foot Ulcer Assessment and Management #Streptococcal Infections and Treatments
paper · doi:10.34763/devperiodmed.20192302.142148
openalex created_date 2019/12/05 · openalex publication_date 2020/12/31 · openalex updated_date 2026/07/01
Hyperbaric oxygen therapy (HBOT), which is a centuries-old treatment, has now increasingly often been used in the pediatric population. The basic indications for HBOT are well-known disease entities, i.e. carbon monoxide poisoning or decompression sickness. Due to the immunomodulatory properties of hyperbaric oxygen, attempts are made to use HBOT in the treatment of atopic dermatitis or inflammatory bowel diseases. The close cooperation between pediatricians and hyperbaric medicine teams is very important to obtain optimal results. The aim of this article is to present the mechanism of hyperbaric oxygen activity, and its influence on selected disease entities. The paper outlines new perspectives for HBOT in the pediatric population.